Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

980 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early impairment in mitochondrial quality check and function precedes the development of cardiac phenotypes in an mouse model of Fabry Disease.
Gambardella J, Fiordelisi A, Cerasuolo FA, Buonaiuto A, Avvisato R, Viti A, Sommella E, Campiglia P, D'Argenio V, Prevete N, D'Apice S, Varzideh F, Paolillo R, Perrino C, Riccio E, Pisani A, Bianco A, Sadoshima J, Spinelli L, Santulli G, Sorriento D, Iaccarino G. Gambardella J, et al. Among authors: pisani a. Vascul Pharmacol. 2024 Jun;155:107320. doi: 10.1016/j.vph.2024.107320. Vascul Pharmacol. 2024. PMID: 38985588 No abstract available.
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations.
Gambardella J, Riccio E, Bianco A, Fiordelisi A, Cerasuolo FA, Buonaiuto A, Di Risi T, Viti A, Avvisato R, Pisani A, Sorriento D, Iaccarino G. Gambardella J, et al. Among authors: pisani a. Front Cardiovasc Med. 2024 Jan 24;11:1341590. doi: 10.3389/fcvm.2024.1341590. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38327490 Free PMC article. Review.
Assessing brain involvement in Fabry disease with deep learning and the brain-age paradigm.
Montella A, Tranfa M, Scaravilli A, Barkhof F, Brunetti A, Cole J, Gravina M, Marrone S, Riccio D, Riccio E, Sansone C, Spinelli L, Petracca M, Pisani A, Cocozza S, Pontillo G. Montella A, et al. Among authors: pisani a. Hum Brain Mapp. 2024 Apr;45(5):e26599. doi: 10.1002/hbm.26599. Hum Brain Mapp. 2024. PMID: 38520360 Free PMC article.
Diet and Physical Activity in Fabry Disease: A Narrative Review.
Muscogiuri G, De Marco O, Di Lorenzo T, Amicone M, Capuano I, Riccio E, Iaccarino G, Bianco A, Di Risi T, Pisani A. Muscogiuri G, et al. Among authors: pisani a. Nutrients. 2024 Apr 4;16(7):1061. doi: 10.3390/nu16071061. Nutrients. 2024. PMID: 38613094 Free PMC article. Review.
A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.
Holida M, Linhart A, Pisani A, Longo N, Eyskens F, Goker-Alpan O, Wallace E, Deegan P, Tøndel C, Feldt-Rasmussen U, Hughes D, Sakov A, Rocco R, Almon EB, Alon S, Chertkoff R, Warnock DG, Waldek S, Wilcox WR, Bernat JA. Holida M, et al. Among authors: pisani a. J Inherit Metab Dis. 2025 Jan;48(1):e12795. doi: 10.1002/jimd.12795. Epub 2024 Oct 9. J Inherit Metab Dis. 2025. PMID: 39381863 Free PMC article. Clinical Trial.
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G; EAGLE Study Group. Ruggenenti P, et al. Among authors: pisani a. Am J Kidney Dis. 2019 Aug;74(2):224-238. doi: 10.1053/j.ajkd.2018.12.046. Epub 2019 Mar 28. Am J Kidney Dis. 2019. PMID: 30929851
980 results